Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients

This study has been terminated.
Sponsor:
Collaborator:
Neurologic AIDS Research Consortium (NARC)
Information provided by:
Savient Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00286377
First received: June 30, 2005
Last updated: February 2, 2006
Last verified: January 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2004
  Estimated Primary Completion Date: No date given
No publications provided by Savient Pharmaceuticals

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):